Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1812744rdf:typepubmed:Citationlld:pubmed
pubmed-article:1812744lifeskim:mentionsumls-concept:C0079522lld:lifeskim
pubmed-article:1812744lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:1812744lifeskim:mentionsumls-concept:C0596052lld:lifeskim
pubmed-article:1812744lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:1812744lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:1812744lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:1812744lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:1812744pubmed:dateCreated1992-6-10lld:pubmed
pubmed-article:1812744pubmed:abstractTextScheme 1 summarizes some of what we have learned from this study of non-viral protein substrates of the HIV proteases. Many of these findings contradict the current understanding of protease specificity. P1-P1' amino acids need not be bulky or hydrophobic and residues at these positions may be even less important than those in flanking positions (e.g., Glu at P2') in dictating the course of hydrolysis. Thus, the pattern of amino acids over the whole binding region must be considered in predicting what will or will not be a substrate of these enzymes and, although we are beginning to understand selectivity at the level of primary structure, a detailed explanation of their specificity is yet to be forthcoming. Nevertheless, studies of this kind find useful application in the design of inhibitors of HIV proteases that will, hopefully, be of value in treatment of AIDS.lld:pubmed
pubmed-article:1812744pubmed:languageenglld:pubmed
pubmed-article:1812744pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:citationSubsetIMlld:pubmed
pubmed-article:1812744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1812744pubmed:statusMEDLINElld:pubmed
pubmed-article:1812744pubmed:issn0065-2598lld:pubmed
pubmed-article:1812744pubmed:authorpubmed-author:HeinriksonR...lld:pubmed
pubmed-article:1812744pubmed:authorpubmed-author:HesterJ BJBlld:pubmed
pubmed-article:1812744pubmed:authorpubmed-author:SawyerT KTKlld:pubmed
pubmed-article:1812744pubmed:authorpubmed-author:TomasselliA...lld:pubmed
pubmed-article:1812744pubmed:authorpubmed-author:XieY XYXlld:pubmed
pubmed-article:1812744pubmed:authorpubmed-author:ThaisrivongsS...lld:pubmed
pubmed-article:1812744pubmed:issnTypePrintlld:pubmed
pubmed-article:1812744pubmed:volume306lld:pubmed
pubmed-article:1812744pubmed:ownerNLMlld:pubmed
pubmed-article:1812744pubmed:authorsCompleteYlld:pubmed
pubmed-article:1812744pubmed:pagination469-82lld:pubmed
pubmed-article:1812744pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:meshHeadingpubmed-meshheading:1812744-...lld:pubmed
pubmed-article:1812744pubmed:year1991lld:pubmed
pubmed-article:1812744pubmed:articleTitleThe evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapy.lld:pubmed
pubmed-article:1812744pubmed:affiliationUpjohn Laboratories, Upjohn Company, Kalamazoo, Michigan 49001.lld:pubmed
pubmed-article:1812744pubmed:publicationTypeJournal Articlelld:pubmed